Lesion-specific circRNAs and linear mRNAs in Secondary Progressive Multiple Sclerosis (SPMS)
The study identified specific circular RNAs (circRNAs) and linear mRNAs related to different types of lesions in secondary progressive multiple sclerosis. These dysregulated circRNAs were linked to synaptic organization, intracellular signaling, immune responses, and chromatin regulation.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not yet assessed
- Mechanism
- Not yet assessed
- Evidence strength
- Not yet assessed
- Outcome
- Not yet assessed
Why it matters
This research provides insight into the molecular mechanisms associated with SPMS lesions, revealing potential pathways that may influence disease progression or pathology.
What this does not prove
This study does not establish clinical efficacy or provide results from human trials. It focuses on transcriptomic analysis and may not directly correlate to therapeutic outcomes.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-07-22
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceLesion-specific circular RNA and mRNA signatures in secondary progressive multiple sclerosis. ↗DOI: 10.1186/s13041-026-01333-y
Supporting passages (3)
publication datePublication date: 2026-07-22
findingsOur results highlight that circRNAs-associated networks exhibit lesion-specific expression and structural diversity in SPMS and may participate in MS-associated biological processes.
limitationsTitle: Lesion-specific circular RNA and mRNA signatures in secondary progressive multiple sclerosis.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.